For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Blog
How State Directed Payments turned Medicaid into an interstate transfer scheme
Medicaid’s financing rules have long allowed states to expand spending while shifting much of the cost to federal taxpayers. One of the most important…
Blog
Medicaid financing gimmickry – before and after the One Big Beautiful Bill
Medicaid was created in 1965 as a joint federal-state health insurance program for low-income individuals which targeted families with dependent children, the elderly, and…
Search Posts
Inside Sources
The Double Standard for Nicotine and Cannabis
The U.S. House of Representatives may soon vote on a historic measure to end federal prohibition on cannabis. Ironically, just as the public…
Study
The Double Standards of Cannabis and Nicotine
View Full Document as PDF Executive Summary The principal benefit of recreational cannabis, as the name implies, is recreation. Many who…
National Review
Cancel Culture Comes to Medicine
Cancel culture has come to medicine. Dr. Scott Atlas, who was chairman of neuroradiology at Stanford’s medical school until 2012 and more recently a senior…
News Release
Report: Politics, Not Science, Drives Double Standard on Cannabis, Nicotine Policies
As the House votes on a bill this month to end the federal prohibition on cannabis – once unthinkable – a new Competitive…
Blog
Trump’s Drug Price Controls are a Lousy Deal for Patients
Prescription drug prices are popular targets for lawmakers—especially in an election year. Still, it came as quite a surprise when President Trump issued an…
The Washington Examiner
Government Alcohol Advice Should be Based on Evidence, Not Agendas
Should adults cut their alcohol consumption in half for health reasons? That’s what a federal government advisory committee is recommending. It matters because…